The latest research implicates that the PISK/AKT pathway is involved in radiotherapy resistance in HCC patients, and ablation of PDK1 function might improve radiosensitivity and is associated with deactivated PI3K/AKT/mTOR signaling [43]. The gene discussed is MTOR; the disease is hepatocellular carcinoma.